Methyl (3S,6S,9aS)-6-((tert-butoxycarbonyl)amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate

Catalog No. :
ACWFXZ577
CAS No. :
328974-84-1
Molecular Formula :
C16H26N2O5
Molecular Weight :
326.39

IUPAC Name:methyl (3S,6S,9aS)-6-((tert-butoxycarbonyl)amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate

Methyl (3S,6S,9aS)-6-((tert-butoxycarbonyl)amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$1525.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (3S,6S,9aS)-6-((tert-butoxycarbonyl)amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate
IUPAC Namemethyl (3S,6S,9aS)-6-((tert-butoxycarbonyl)amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate
MDL No.MFCD35146344
Molecular FormulaC16H26N2O5
Molecular Weight326.39
SMILESO=C([C@@H]1CC[C@@](CCC[C@@H]2NC(OC(C)(C)C)=O)([H])N1C2=O)OC
InChI KeyOIIOGKCRACRASR-SRVKXCTJSA-N
Synonym1H-Pyrrolo[1,2-a]azepine-3-carboxylic acid, 6-[[(1,1-dimethylethoxy)carbonyl]amino]octahydro-5-oxo-, methyl ester, (3S,6S,9aS)-;(3S,6S,9aS)-methyl 6-((tert-butoxycarbonyl)amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate;Methyl (3S,6S,9aS)-6-(Boc-amino)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxylate
CAS No.328974-84-1

Synthetic Route by SureRoute

1. ACWFXZ577 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWFXZ577 route product structure diagram
    ACWFXZ577328974-84-1
Inquiry

2. ACWFXZ577 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWFXZ577 route product structure diagram
    ACWFXZ577328974-84-1
Inquiry

Comments (0)